Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images
arXiv:1710.04782
Abstract
Alzheimer's Disease (AD) is a progressive neurodegenerative disease. Amnestic mild cognitive impairment (MCI) is a common first symptom before the conversion to clinical impairment where the individual becomes unable to perform activities of daily living independently. Although there is currently no treatment available, the earlier a conclusive diagnosis is made, the earlier the potential for interventions to delay or perhaps even prevent progression to full-blown AD. Neuroimaging scans acquired from MRI and metabolism images obtained by FDG-PET provide in-vivo view into the structure and function (glucose metabolism) of the living brain. It is hypothesized that combining different image modalities could better characterize the change of human brain and result in a more accuracy early diagnosis of AD. In this paper, we proposed a novel framework to discriminate normal control(NC) subjects from subjects with AD pathology (AD and NC, MCI subjects convert to AD in future). Our novel approach utilizing a multimodal and multiscale deep neural network was found to deliver a 85.68\% accuracy in the prediction of subjects within 3 years to conversion. Cross validation experiments proved that it has better discrimination ability compared with results in existing published literature.
arXiv comment12 pages, 4 figures, Alzheimer's disease, deep learning, multimodal, early diagnosis, multiscale
References in corpus (4)
Cited by in corpus (4)
- Deep Learning in Alzheimer's disease: Diagnostic Classification and Prognostic Prediction using Neuroimaging Data
- TorchIO: A Python library for efficient loading, preprocessing, augmentation and patch-based sampling of medical images in deep learning
- Layer-Wise Relevance Propagation for Explaining Deep Neural Network Decisions in MRI-Based Alzheimer's Disease Classification
- NEURO-DRAM: a 3D recurrent visual attention model for interpretable neuroimaging classification